Barclays Reaffirms Their Buy Rating on Amneal Pharmaceuticals …

3 days ago · Barclays analyst Balaji Prasad maintained a Buy rating on Amneal Pharmaceuticals (AMRX – Research Report) today and set a price target of $10.00. The company’s shares closed last Friday at $8.73.

CouponFollow Extension

$10.00
OFF

Barclays Reaffirms Their Buy Rating On Amneal Pharmaceuticals …

2 weeks from now

businessinsider.com

$8.00
OFF

Amneal Pharmaceuticals (NASDAQ:AMRX) Hits New 1-Year High

2 weeks from now

3 days ago · Finally, Barclays lifted their price target on shares of Amneal Pharmaceuticals from $8.00 to $10.00 and gave the company an "overweight" rating in a report on Tuesday, August …

marketbeat.com

$10.00
OFF

Amneal Pharmaceuticals (NASDAQ:AMRX) Updates FY 2024

2 weeks from now

6 days ago · Truist Financial upped their target price on Amneal Pharmaceuticals from $10.00 to $12.00 and gave the company a "buy" rating in a report on Wednesday, October 2nd. Finally, …

marketbeat.com

$11
OFF

Amneal Pharmaceuticals Price Target Raised To $11 From $9 At …

2 weeks from now

3 days ago · Piper Sandler raised the firm’s price target on Amneal Pharmaceuticals to $11 from $9 and keeps an Overweight rating on the shares.The firm notes Amneal reported Q3 adjusted …

businessinsider.com

$9.40
OFF

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives $9.40

2 weeks from now

Oct 26, 2024 · Finally, Barclays increased their price objective on Amneal Pharmaceuticals from $8.00 to $10.00 and gave the company an "overweight" rating in a research note on Tuesday, …

marketbeat.com

$6
OFF

Our First Assessment Of Amneal Pharmaceuticals Stock - Seeking …

2 weeks from now

Mar 14, 2021 · In this case it's around a $6 developmental concern name Amneal Pharmaceuticals ... have reissued Hold ratings while Barclays ($8 price target) maintained …

seekingalpha.com

$8.00
OFF

Barclays Reaffirms Their Buy Rating On Amneal Pharmaceuticals …

2 weeks from now

May 13, 2024 · Barclays analyst Balaji Prasad maintained a Buy rating on Amneal Pharmaceuticals (AMRX – Research Report) today and set a price target of $8.00.The …

businessinsider.com

$8.00
OFF

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Consensus …

2 weeks from now

Oct 1, 2024 · Barclays boosted their price objective on Amneal Pharmaceuticals from $8.00 to $10.00 and gave the company an "overweight" rating in a research report on Tuesday, August …

marketbeat.com

39%
OFF

Amneal Pharmaceuticals Stock Forecast - Stock Analysis

2 weeks from now

6 days ago · Amneal Pharmaceuticals, Inc. (AMRX) NASDAQ: AMRX · Real-Time Price · USD. Watchlist Compare. 8.73 +0.12 (1.39%) ... Analyst Ratings. The average analyst rating for …

stockanalysis.com

$8.00
OFF

Nisa Investment Advisors LLC Sells 221,848 Shares Of Amneal ...

2 weeks from now

5 days ago · Barclays increased their price objective on Amneal Pharmaceuticals from $8.00 to $10.00 and gave the stock an "overweight" rating in a research report on Tuesday, August …

marketbeat.com

$8.00
OFF

Amneal Pharmaceuticals (NASDAQ:AMRX) Rating Increased To …

2 weeks from now

1 day ago · Barclays increased their price objective on shares of Amneal Pharmaceuticals from $8.00 to $10.00 and gave the company an “overweight” rating in a report on Tuesday, August …

etfdailynews.com

58%
OFF

Amneal Pharmaceuticals (AMRX) Gets A Buy From Truist Financial

2 weeks from now

Aug 12, 2024 · The word on The Street in general, suggests a Strong Buy analyst consensus rating for Amneal Pharmaceuticals with a $8.00 average price target, representing a 4.58% …

businessinsider.com

$17.00
OFF

Barclays Reaffirms Their Hold Rating On Pacira Pharmaceuticals …

2 weeks from now

2 days ago · In a report released today, Balaji Prasad from Barclays maintained a Hold rating on Pacira Pharmaceuticals (PCRX – Research Report), with a price target of $17.00. The …

businessinsider.com

FAQs about Barclays Reaffirms Their Buy Rating on Amneal Pharmaceuticals … Coupon?

Is Amneal Pharmaceuticals stock a good buy?

Amneal Pharmaceuticals stock has received a consensus rating of buy. The average rating score is and is based on 10 buy ratings, 0 hold ratings, and 0 sell ratings. What was the 52-week low for Amneal Pharmaceuticals stock? The low in the last 52 weeks of Amneal Pharmaceuticals stock was 3.37. ...

Should you buy Amneal Pharmaceuticals (AMRX – research report)?

Barclays analyst Balaji Prasad maintained a Buy rating on Amneal Pharmaceuticals ( AMRX – Research Report) today and set a price target of $8.00. The company’s shares closed last Friday at $6.66. According to TipRanks, Prasad is a 4-star analyst with an average return of 3.5% and a 44.78% success rate. ...

What is the target price for Amneal Pharmaceuticals?

The 10 analysts offering price forecasts for Amneal Pharmaceuticals have a median target of 5.43, with a high estimate of 8.00 and a low estimate of 3.00. The median estimate represents a 154.29 difference from the last price of 8.37. *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. ...

How far is Amneal Pharmaceuticals stock from the 52-week high?

According to the current price, Amneal Pharmaceuticals is 93.00% away from the 52-week high. What are analysts forecasts for Amneal Pharmaceuticals stock? The 10 analysts offering price forecasts for Amneal Pharmaceuticals have a median target of 5.43, with a high estimate of 8.00 and a low estimate of 3.00. ...

Is Amneal a buy?

Further bolstering the Buy rating is Amneal’s aggressive product pipeline, with over 30 new product launches anticipated for 2025, and an expected increase in AvKARE revenue. Additionally, the planned second-half 2024 launch of IPX-203, which has not yet been factored into guidance, presents an upside potential. ...

What was the closing price of Amneal Pharmaceuticals Inc registered SS -a- share?

On Wednesday 09/11/2024 the closing price of the Amneal Pharmaceuticals Inc Registered Shs -A- share was $8.37 on BTT. Compared to the opening price on Wednesday 09/11/2024 on BTT of $8.24, this is a gain of 1.55%. Amneal Pharmaceuticals Inc Registered Shs -A-'s market capitalization is $2.22 B by 309.54 M shares outstanding. ...